Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. - Wikidata - wikimedia - TriplyDB

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.

http://www.wikidata.org/entity/Q34132358

about

KRIB MNNG/HOS Cl #5 CCH-OS-D K7M3

P1343

Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma.Osteosarcoma Overview.Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis.ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone.Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment.Strategies and developments of immunotherapies in osteosarcoma Immune Therapy for Sarcomas.Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma.MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate.Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis.Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.Aerosol Delivery of Interleukin-2 in Combination with Adoptive Transfer of Natural Killer Cells for the Treatment of Lung Metastasis: Methodology and Effect.Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.

P2860

Q54900481-C2241799-2416-42BD-B9E0-1EB335422328 Q54906271-245FABC8-27F5-4F53-8B48-C46CFA820892 Q93445405-7553D871-3EC5-4CB2-900B-594F2B9DD232 Q94336003-45A3AD97-16D3-4CCD-89FB-082745F26498

P1343

Q28085397-C5B95B10-5FC9-45C2-8C0F-7F33C894A7B1 Q33607479-E60DCCB9-249E-480B-8B84-F3E287709C1B Q33725511-E8483A29-48F7-4FCE-A727-D8DAF7BDFB55 Q34088081-CEE05E25-25F2-4C94-ACA1-8A85595AC750 Q34357258-78947766-10A5-4D7E-B190-47D5E3061B63 Q35894540-03E3A620-DDF9-43E6-8C9A-D9EF9D71CE34 Q36107932-9875825A-8B22-49D1-BDCF-C882CD494810 Q36503128-115500FE-D778-42D0-A92E-6AF971DA83C2 Q38742533-69F072E6-54F1-4059-BEC8-EE37E5C5299F Q38784430-10B22F82-FD57-4AC7-A9B1-68BF9D61A75E Q40825745-EDAC7413-71D8-4C99-8686-7C12D20476E7 Q47106247-E852551A-8129-4C8D-9074-B2BCB1F3F9C7 Q47788129-909DAD0C-8353-4337-89B0-32EB1E0A8A7F Q48378796-B3CD016E-843C-46D6-A9E1-9EF87E1A2914 Q50034069-7C01EF7A-CA0F-47AC-9459-167C4695D815 Q53101320-A351F89F-C687-482B-B6B0-DCE54DE5D1FC Q55323964-6B91D4C5-BA02-4499-9704-CB4B0F3450A7

P2860

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.

http://www.wikidata.org/entity/Q34132358

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@ast

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@en

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@nl

type

label

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@ast

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@en

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@nl

prefLabel

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@ast

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@en

Natural killer cell therapy an ...... osteosarcoma lung metastasis.

@nl

P1433

Q34132358-52F205B7-E394-423C-BAA9-E23F3429A119

P1476

Q34132358-1B5F0F65-4C11-4BC4-82B0-945BA41F8D56

P2093

Q34132358-04BDE846-74EF-45FF-8EF0-4A3FB821482F

Q34132358-1D80FE77-FC45-4D4C-AA50-2FE9551CFB86

Q34132358-4AA0BAEB-2679-4AAD-9385-FD00E91C2140

Q34132358-4C4E4646-FD19-453B-BF7C-A7C972206D1E

Q34132358-A302383C-A40B-4E4A-A8B8-E39F70FF1491

Q34132358-BF04D3A7-697B-4D55-8544-3870A7160712

Q34132358-FDD06CE2-AF28-46BE-A19C-1BEA82827ABD

P2860

Q34132358-158AA567-18EF-4C1F-BCD5-8A4837AD3535

Q34132358-175E31C6-8C73-4B78-BFED-B6C80F798DE6

Q34132358-1EE70D88-1D6B-49FE-BF2D-738071841694

Q34132358-25E065A2-31AC-460D-96E4-09D683BE3679

Q34132358-2DBCE191-297A-4186-A879-2E928302E054

Q34132358-2DD6B811-72AA-4F3C-8F35-3DDF6A03704E

Q34132358-33221937-F236-4C5C-8CFE-136CC8FAA978

Q34132358-34A65526-1DBB-421B-97BF-D95771A9FC27

Q34132358-35E759AF-CA43-4789-8BEC-5D8FC5F8722D

Q34132358-38835734-EED8-4D8E-A21A-830DADE31663

P304

Q34132358-BA67D19D-4B78-4FCD-AF55-0C2BDE5CE5A8

P31

Q34132358-F45C11AD-81E2-4DB3-BDED-5E16A19DBE17

P356

Q34132358-A2C41A4B-065D-457C-9C1C-594D6EB92B75

P433

Q34132358-BF4DEDF9-3038-4E21-82B3-187D1D138324

P478

Q34132358-2CEF05DC-942A-4E74-A51B-68513C08FD36

P50

Q34132358-BDA4B6E4-3454-4DF2-AD25-DDC0E0B61051

P577

Q34132358-7D352BC2-0024-4267-9A86-BC0A5CDDF212

P698

Q34132358-9B1B438F-F7A7-49AC-A83B-97536773EB89

P932

Q34132358-57E868DC-8B9F-46EF-835A-03B15E5C093C

P356

P1433

Pediatric Blood & Cancer

P1476

Natural killer cell therapy an ...... f osteosarcoma lung metastasis

@en

P2093

Dennis Hughes

http://www.w3.org/2001/XMLSchema#string

Eugenie S Kleinerman

http://www.w3.org/2001/XMLSchema#string

John Stewart

http://www.w3.org/2001/XMLSchema#string

Ling Yu

http://www.w3.org/2001/XMLSchema#string

Nancy Gordon

http://www.w3.org/2001/XMLSchema#string

Sergei R Guma

http://www.w3.org/2001/XMLSchema#string

Wei Lien Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected]

Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

P304

618-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24801

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24136885

http://www.w3.org/2001/XMLSchema#string

P932

4154381

http://www.w3.org/2001/XMLSchema#string